Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2022.04.005
PubMed Identifier: 35643841
Publication URI: http://europepmc.org/abstract/MED/35643841
Type: Journal Article/Review
Volume: 170
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049